MIH
TMO icon

Meitav Investment House’s Thermo Fisher Scientific TMO Stock Holding History

Meitav Investment House’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-451
Closed -$239K – 345
2023
Q4 		$239K Sell
451
-71,869
-99% -$34.8M ﹤0.01% 311
2023
Q3 		$36.7M Sell
72,320
-1,007
-1% -$537K 0.59% 55
2023
Q2 		$37.8M Sell
73,327
-1,963
-3% -$1.06M 0.61% 49
2023
Q1 		$42.4M Buy
75,290
+1,665
+2% +$938K 0.73% 43
2022
Q4 		$41.1M Sell
73,625
-6
-0% -$3.18K 0.71% 41
2022
Q3 		$38M Buy
73,631
+25,518
+53% +$14.3M 0.67% 45
2022
Q2 		$25.9M Sell
48,113
-535
-1% -$294K 0.44% 55
2022
Q1 		$28.5M Buy
48,648
+40,254
+480% +$23.1M 0.42% 58
2021
Q4 		$5.58M Sell
8,394
-47,042
-85% -$29.4M 0.09% 155
2021
Q3 		$31.7M Buy
55,436
+10,983
+25% +$6.03M 0.52% 60
2021
Q2 		$22.4M Buy
44,453
+131
+0.3% +$61.8K 0.57% 53
2021
Q1 		$20.2K Buy
44,322
+1,729
+4% +$825K 0.57% 55
2020
Q4 		$19.8M Sell
42,593
-16,827
-28% -$7.89M 0.78% 54
2020
Q3 		$26.2M Buy
59,420
+1,281
+2% +$529K 1.3% 26
2020
Q2 		$21.1M Buy
58,139
+8,672
+18% +$2.91M 1.26% 24
2020
Q1 		$14M Buy
+49,467
New +$15.6M 1.05% 34

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Meitav Investment House's TMO Position: Q1 2024 in Review

Meitav Investment House sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 451 shares — an estimated $239K sold.

Meitav Investment House first reported a position in TMO in Q1 2020 and held it in 16 quarters. The position peaked at $42.4M in Q1 2023. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Meitav Investment House reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Meitav Investment House sold 451 Thermo Fisher Scientific shares in Q1 2024, an estimated $239K.
  • Meitav Investment House first reported a position in Thermo Fisher Scientific in Q1 2020 and held it in 16 quarters.
  • Meitav Investment House's Thermo Fisher Scientific position peaked at $42.4M in Q1 2023.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Meitav Investment House's 13F filing for Q1 2024, filed 1 May 2024.